Herpes symptoms after a new exposure typically appear within about two to twelve days, with an average around six days. But that timeline only tells part of the story, because the majority of people who contract genital herpes never develop noticeable symptoms at all. When to test depends on whether you have visible sores and what kind of test you are using, since swab tests and blood tests operate on completely different clocks.
The Typical Incubation Period
After sexual contact with someone who has active genital herpes, the incubation period for a first outbreak averages about six days, with most first episodes appearing somewhere between two and twelve days after exposure.1PubMed. Herpesvirus A first episode usually looks like clusters of small, painful blisters or ulcers on or near the genitals, sometimes accompanied by flu-like symptoms such as fever, swollen lymph nodes, and body aches. These initial outbreaks tend to be the most severe, and lesions can take two to four weeks to fully heal without antiviral treatment.
That said, the range is wider than the average suggests. Some people notice tingling or irritation within a day or two of exposure. Others might not develop any recognizable sores for weeks, especially if their immune system partially suppresses the first episode into something so mild it gets mistaken for an ingrown hair, a yeast infection, or simple skin irritation. There is no single “day X” when you can be certain nothing will appear.
Most New Infections Produce No Obvious Symptoms
One of the most important and least appreciated facts about herpes is that the majority of new infections are clinically silent. In a large prospective study tracking people who acquired HSV-2, only about 37 percent developed symptoms they recognized as herpes.2PubMed. A prospective study of new infections with herpes simplex virus type 1 and type 2 The remaining roughly two-thirds either had no symptoms at all or had symptoms so mild they were attributed to something else entirely.
This has a big practical consequence. If you are waiting to see whether symptoms appear before deciding to get tested, you are relying on a signal that the virus frequently does not send. You can be infected, contagious, and completely unaware. This is one reason herpes spreads as efficiently as it does: the people passing it along often have no idea they carry it.
Even among those who do develop a first clinical episode, there is an additional wrinkle. Some people acquire the virus, remain asymptomatic for months or even years, and then have what they think is a “first outbreak” but is actually a recurrence of an older, unnoticed infection. Research has found that people presenting with apparent first-episode symptoms sometimes already have antibodies indicating they were infected much earlier. Their lesions tend to heal faster and recur less frequently than true primary infections.3Sexually Transmitted Diseases. Clinical Course of Patients With Serologic Evidence of Recurrent Genital Herpes Presenting With Signs and Symptoms of First Episode Disease So even the timing of visible symptoms does not reliably tell you when you were actually exposed.
Swab Tests Work Best During an Active Outbreak
If you have a sore, blister, or ulcer, the fastest and most accurate path to a diagnosis is having a clinician swab the lesion directly. The two main swab-based methods are viral culture and PCR (polymerase chain reaction), and the difference between them matters.
Viral culture was the standard for decades, but it misses a substantial number of infections. In one head-to-head comparison, culture detected herpes in about 34 percent of swabbed samples, while PCR detected it in 57 percent of those same samples.4Sexually Transmitted Infections. Diagnosis of genital herpes by real time PCR in routine clinical practice PCR was better at catching both early and late presentations and worked well in both first episodes and recurrences. The gap is large enough that if your provider offers only culture, it is worth asking about PCR.
More recent comparisons have confirmed this pattern. A study testing multiple detection methods side by side found PCR-based assays catching upwards of 95 percent of true positives, while culture and older immunofluorescence methods lagged behind.5PubMed Central. Comparison of Simplexa HSV 1 & 2 PCR with culture, immunofluorescence, and laboratory-developed TaqMan PCR for detection of herpes simplex virus in swab specimens Multiplex PCR assays, which can identify HSV-1, HSV-2, and varicella-zoster virus simultaneously from a single swab, have further improved sensitivity and turnaround time.6PubMed. Development of a multiplex real-time PCR for the simultaneous detection of herpes simplex and varicella zoster viruses in cerebrospinal fluid and lesion swab specimens
Timing still matters for swab tests, though. The best results come from swabbing a fresh, unroofed lesion within the first few days. As sores crust over and begin healing, the amount of detectable virus drops, and both culture and PCR become less reliable. If you suspect a herpes sore, get it swabbed as soon as possible rather than waiting to see if it resolves on its own.
Blood Tests and the Antibody Window
Blood tests for herpes do not detect the virus itself. They detect antibodies your immune system produces in response to infection, specifically IgG antibodies that target proteins unique to HSV-1 or HSV-2. This means blood tests are useless immediately after exposure. Your body needs time to mount an antibody response.
Most people develop detectable IgG antibodies within two to six weeks after infection, but it can take up to twelve weeks, and in some individuals slightly longer. Because of this window, the standard guidance is to wait at least twelve weeks after a possible exposure before a blood test can be considered reliable for ruling herpes in or out. Testing earlier might catch someone who seroconverted quickly, but a negative result at four weeks does not mean much. If you had a specific exposure that concerns you, the twelve-week mark is when a negative result actually carries weight.
A common question is whether IgM antibody testing can close this gap by detecting an acute new infection before IgG appears. In theory, IgM rises earlier. In practice, type-specific IgM blood tests for herpes have proven unreliable. An evaluation of commercial IgM assays found that HSV-1-specific and HSV-2-specific IgM tests did not dependably detect type-specific IgM antibodies.7PubMed. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays While combined IgM tests (not distinguishing type 1 from type 2) showed some utility for confirming acute newly acquired infections, the single-type versions were essentially useless. Most guidelines now discourage routine IgM testing for genital herpes because it generates confusion without providing reliable answers.
The False Positive Problem with Blood Tests
Even among the more dependable IgG blood tests, false positives are a genuine concern, and the risk depends heavily on which commercial assay your lab uses and what your result’s index value looks like.
Most IgG tests report a numerical index value rather than a simple positive or negative. A value above a certain cutoff is called “positive,” but not all positives are created equal. A large study comparing three widely used commercial platforms found striking differences. The DiaSorin assay performed poorly at low-positive index values: about 61 percent of its HSV-1 “positives” and about 21 percent of its HSV-2 “positives” with index values below 3.0 were actually false positives. When accounting for how common HSV-2 actually is in the United States (around 12 percent of the adult population), nearly one in three positive DiaSorin HSV-2 IgG results would be falsely positive. The Roche platform, by contrast, had a positive predictive value above 96 percent for HSV-2.8PubMed Central. Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing
The CDC has recommended that positive HSV-2 IgG screening results with low index values (between 1.10 and 3.50) should be confirmed with a second test before being trusted. But even this guidance may not catch all false positives. One study found that a substantial portion of false positives had index values above 3.50, meaning they would be incorrectly treated as confirmed positives under the CDC’s recommendation.9Diagnostic Microbiology and Infectious Disease. Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results
The gold standard for confirming an HSV-2 blood test result is the Western blot assay, which uses a completely different approach to identify type-specific antibodies. It remains the most accurate serological method available, though access to it is limited because it has historically been restricted to research and reference laboratories.10PubMed. The reliability of serological tests for the diagnosis of genital herpes: a critique If you receive a low-positive result on a standard IgG screening test and have no history of symptoms or known exposure, requesting a confirmatory test is reasonable before accepting the diagnosis.
What to Do If You Have No Symptoms and No Active Sores
This is where testing gets frustrating. Without an active lesion to swab, you are left with the blood test, and blood tests come with the window period and false-positive issues described above. If you had a specific recent exposure and want to know your status, here is a practical timeline:
- First two weeks: Watch for any unusual genital symptoms. If sores appear, get them swabbed with PCR immediately. Do not wait for a blood test.
- Three to four weeks: A blood test at this point might catch an early seroconverter, but a negative result is not yet reliable. If the test comes back positive, it could reflect an older infection rather than the recent exposure.
- Twelve weeks: This is the earliest a negative IgG result is considered trustworthy. Most people who are going to seroconvert have done so by this point.
- Beyond twelve weeks: If the twelve-week test is negative and you have not had any sores, the specific exposure you were worried about almost certainly did not result in infection.
One complication worth knowing: a positive HSV-1 IgG result does not tell you the location of the infection. HSV-1 causes most oral cold sores but also accounts for a growing share of genital herpes. If you test positive for HSV-1 antibodies, you cannot tell from the blood test whether you have oral HSV-1 (which most adults acquired in childhood), genital HSV-1, or both. Only a swab of an active lesion can identify the site of infection.
Asymptomatic Shedding and Transmission Between Outbreaks
After the initial infection clears, the virus does not leave the body. It retreats along sensory nerve fibers into clusters of nerve cells called ganglia near the spine, where it remains dormant indefinitely.11The Journal of Infectious Diseases. The Cycle of Human Herpes Simplex Virus Infection: Virus Transport and Immune Control Periodically, the virus reactivates and travels back to the skin surface, sometimes causing visible outbreaks but often producing no symptoms at all. During these silent reactivations, infectious virus is present on the skin, a phenomenon called asymptomatic shedding.
Shedding is most frequent in the months right after you first acquire the virus. A study of women after their first episode found that asymptomatic cervical shedding of HSV-2 was three times more common during the first three months compared to later periods.12PubMed Central. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes Asymptomatic shedding was detected in roughly 23 percent of women with nonprimary HSV-2 infections and about 18 percent of those with primary HSV-2 infections at any given follow-up visit. These numbers represent snapshots in time; the actual frequency with which shedding episodes occur across weeks and months is even higher than any single sampling day would suggest.
The practical implication is that someone with genital herpes can transmit the virus even when they feel completely fine and see no sores. This is why daily suppressive antiviral therapy and consistent condom use are recommended for people who know they carry HSV-2 and have partners who do not, as these measures reduce (but do not eliminate) the risk of transmission.
Herpes Testing During Pregnancy
Herpes takes on an added layer of urgency during pregnancy because of the risk of neonatal herpes, a rare but serious condition. The timing of a maternal infection relative to delivery is what matters most. If a woman acquires genital herpes for the first time during the second half of pregnancy, the risk of transmitting the virus to the baby during vaginal delivery is highest.13PubMed Central. Herpes simplex virus infection in pregnancy This is because there has not been enough time for the mother to develop protective antibodies that would cross the placenta and offer the baby some passive immunity.
A study that followed pregnant women who acquired HSV during pregnancy found that when seroconversion was completed well before labor, there was no increase in neonatal problems and no cases of congenital herpes. But among the small number of women who acquired genital herpes shortly before labor, neonatal HSV infection occurred in nearly half of their infants, and one of those infants died.14PubMed. The acquisition of herpes simplex virus during pregnancy The difference is stark enough that many clinicians recommend type-specific serological testing early in pregnancy for women whose partners have known genital herpes, so that susceptible women can take precautions to avoid acquiring the virus late in pregnancy.
For women who already have genital herpes before becoming pregnant, the situation is much less dire. They have pre-existing antibodies that cross the placenta and provide the baby with some protection. The main concern is having active lesions at the time of delivery, which is typically managed with suppressive antiviral therapy in the final weeks of pregnancy and, if lesions are present when labor begins, delivery by cesarean section.
Why Routine Screening Is Not Recommended for Everyone
Given how common herpes is and how often it goes unrecognized, you might wonder why health authorities do not just screen everybody. The U.S. Preventive Services Task Force and the CDC have both declined to recommend universal herpes screening in asymptomatic adults, and the false-positive problem is a major reason. In a population where only about 12 percent of people carry HSV-2, running a screening test with even a modest false-positive rate generates a large number of incorrect diagnoses relative to the true positives it catches. The emotional and psychological consequences of a herpes diagnosis are well documented, and telling someone they have herpes when they do not causes real harm.
There is also the question of clinical benefit. For most asymptomatic carriers, knowing their HSV-2 status does not change their medical management. They are not having outbreaks to treat. Whether counseling them to disclose to partners or use antivirals actually reduces population-level transmission has not been convincingly demonstrated. The testing infrastructure, with its window periods, platform-dependent accuracy, and need for confirmatory Western blots, adds cost and complexity that screening advocates have not been able to justify for the general population.
Targeted testing makes much more sense. If you have symptoms, get swabbed. If you had a specific exposure and are anxious about it, get a type-specific IgG blood test at twelve weeks. If you are pregnant and your partner has herpes, get tested early so you and your provider can plan accordingly. If you are living with HIV or have another condition that affects your immune system, knowing your HSV status has clearer clinical implications. Outside these scenarios, the test is available if you want it, but the results require more interpretation than most people expect.
Navigating Partner Conversations and Lookback Periods
One of the hardest questions after a herpes diagnosis is figuring out who you might have gotten it from and who you might have exposed. Because so many infections are asymptomatic and the virus can reactivate silently for years before causing a recognizable outbreak, pinning down the timing of acquisition is often impossible. A first recognized outbreak is not the same thing as a first infection, and a positive blood test does not come with a timestamp.
For other sexually transmitted infections, contact-tracing guidelines use specific lookback periods tied to incubation windows. For herpes, this approach breaks down because the gap between infection and first recognized symptoms can range from days to years. If your concern is notifying a current partner, the conversation is valuable regardless of who infected whom, because it affects how you manage risk together going forward. If your concern is determining whether a specific past partner was the source, the honest answer is that the testing and the biology usually cannot provide that certainty.
What is clear is that viral shedding, and therefore transmission risk, is highest in the first year after acquisition and particularly the first few months.12PubMed Central. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes If you have recently been diagnosed, the people most at risk of having been exposed are your most recent sexual partners. Having a direct, factual conversation about herpes with them allows them to watch for symptoms, consider testing, and make informed decisions about their own health.